StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
7
Publishing Date
2021 - 04 - 16
7
Sector
Finance
1
Health technology
5
Process industries
1
Tags
Approval
5
Brazil
1
Cancer
4
Drug
1
Events
1
Fda
2
Fda approval
2
Food
1
Health
1
Immunotherapy
1
N/a
5
Nivolumab
2
Product-news
1
Therapy
1
Treatment
1
Entities
Abbvie inc.
1
Agios pharmaceuticals, inc.
1
Alnylam pharmaceuticals, inc.
1
Amgen inc.
1
Aveo pharmaceuticals, inc.
1
Bausch health companies inc.
1
Beigene, ltd.
1
Blueprint medicines corporation
1
Bristol-myers squibb company
4
Clovis oncology, inc.
1
Eli lilly and company
1
Epizyme, inc.
1
Exelixis, inc.
1
Illumina, inc.
1
Incyte corporation
1
Karyopharm therapeutics inc.
1
Pfizer, inc.
1
Regeneron pharmaceuticals, inc.
1
Rigel pharmaceuticals, inc.
1
Sanofi
1
Tilray, inc.
1
Tuscan holdings corp. ii
1
Verastem, inc.
1
Y-mabs therapeutics, inc.
1
Symbols
ABBV
1
AGIO
1
ALNY
1
AMGN
1
AVEO
1
BGNE
1
BHC
1
BMY
4
BPMC
1
CLVS
1
EPZM
1
EXEL
1
ILMN
1
INCY
1
KPTI
1
LLY
1
PFE
1
REGN
1
RIGL
1
SNY
1
THCA
1
TLRY
1
VSTM
1
YMAB
1
Exchanges
Nasdaq
3
Nyse
5
Crawled Date
2024 - 02 - 12
12
2023 - 12 - 22
15
2023 - 12 - 21
12
2023 - 12 - 12
11
2023 - 12 - 08
9
2023 - 10 - 16
9
2023 - 10 - 12
11
2023 - 10 - 05
9
2023 - 10 - 02
11
2023 - 09 - 27
9
2023 - 09 - 25
12
2023 - 09 - 21
10
2023 - 07 - 24
9
2023 - 06 - 30
16
2023 - 06 - 21
10
2023 - 06 - 20
14
2023 - 06 - 06
9
2023 - 06 - 05
10
2023 - 05 - 30
11
2023 - 05 - 11
9
2023 - 05 - 03
10
2023 - 05 - 01
12
2023 - 04 - 27
11
2023 - 04 - 17
12
2023 - 03 - 21
10
2023 - 03 - 16
10
2023 - 03 - 15
11
2023 - 02 - 09
9
2023 - 01 - 31
11
2023 - 01 - 30
9
2022 - 12 - 20
11
2022 - 12 - 16
11
2022 - 12 - 13
9
2022 - 06 - 21
9
2022 - 05 - 24
9
2022 - 05 - 03
12
2022 - 04 - 06
9
2022 - 03 - 28
10
2022 - 03 - 16
9
2022 - 03 - 01
10
2022 - 02 - 23
9
2022 - 01 - 31
11
2022 - 01 - 19
9
2022 - 01 - 13
9
2021 - 12 - 16
9
2021 - 12 - 15
12
2021 - 12 - 09
9
2021 - 12 - 01
10
2021 - 09 - 29
9
2021 - 07 - 29
9
2021 - 06 - 29
9
2021 - 06 - 25
10
2021 - 06 - 11
20
2021 - 06 - 10
10
2021 - 05 - 28
13
2021 - 05 - 21
10
2021 - 05 - 04
11
2020 - 12 - 21
10
2020 - 12 - 17
11
2020 - 12 - 03
9
Crawled Time
06:00
1
14:00
1
15:15
1
17:00
1
18:04
2
19:00
1
Source
www.biospace.com
2
www.fda.gov
3
www.globenewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
approved
crawled date :
2021 - 04 - 16
save search
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma....
Published:
2021-04-16
(Crawled : 19:00)
- biospace.com/
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.05%
|
O:
0.76%
H:
1.09%
C:
0.82%
food
therapy
cancer
drug
nivolumab
FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Published:
2021-04-16
(Crawled : 18:04)
- fda.gov
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.05%
|
O:
0.76%
H:
1.09%
C:
0.82%
cancer
fda
fda approval
approval
nivolumab
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-04-16
(Crawled : 18:04)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-32.39%
|
O:
0.72%
H:
2.19%
C:
1.85%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
303.81%
|
O:
0.79%
H:
1.56%
C:
1.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.05%
|
O:
0.76%
H:
1.09%
C:
0.82%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
54.51%
|
O:
0.56%
H:
0.99%
C:
0.39%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-44.65%
|
O:
1.5%
H:
0.22%
C:
-5.38%
VSTM
|
$9.86
-3.62%
-3.75%
150K
|
Health Technology
|
280.3%
|
O:
1.12%
H:
0.0%
C:
-1.47%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.22%
|
O:
0.59%
H:
0.96%
C:
0.61%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-72.22%
|
O:
0.26%
H:
0.0%
C:
-5.54%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
82.19%
|
O:
0.41%
H:
2.06%
C:
1.2%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-86.79%
|
O:
-0.26%
H:
2.95%
C:
0.47%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-36.51%
|
O:
0.5%
H:
0.3%
C:
-1.12%
ILMN
|
$117.43
0.63%
0.63%
1.4M
|
Health Technology
|
-70.57%
|
O:
-0.02%
H:
0.12%
C:
-0.72%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
-3.86%
|
O:
-0.17%
H:
0.84%
C:
-1.34%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-82.14%
|
O:
0.97%
H:
0.24%
C:
-2.59%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.59%
|
O:
-0.66%
H:
1.16%
C:
-1.32%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
-8.37%
|
O:
1.16%
H:
0.0%
C:
-1.92%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-56.45%
|
O:
-0.07%
H:
0.18%
C:
-0.67%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
138.02%
|
O:
-0.95%
H:
0.16%
C:
-0.48%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
3.84%
|
O:
0.51%
H:
0.93%
C:
-0.28%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
4.42%
|
O:
0.41%
H:
0.34%
C:
-0.51%
AGIO
|
$29.52
0.31%
0.3%
750K
|
Health Technology
|
-47.04%
|
O:
-0.45%
H:
2.17%
C:
-0.18%
cancer
approval
FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Published:
2021-04-16
(Crawled : 17:00)
- fda.gov
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.05%
|
O:
0.76%
H:
1.09%
C:
0.82%
cancer
treatment
fda
approval
fda approval
immunotherapy
Tuscan Holdings Corp. II Stockholders Approve Extension of the Date to Consummate Business Combination, Among Other Actions
Published:
2021-04-16
(Crawled : 15:15)
- globenewswire.com
THCA
|
$10.47
|
Finance
|
3.87%
|
O:
-0.89%
H:
1.0%
C:
0.0%
Tilray Board of Directors Announces Approval of Amendment to Company’s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement
Published:
2021-04-16
(Crawled : 14:00)
- biospace.com/
TLRY
|
$1.73
0.58%
0.58%
21M
|
Process Industries
|
-89.73%
|
O:
-1.06%
H:
3.13%
C:
2.63%
approval
BAUSCH HEALTH ANNOUNCES VYZULTA® (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION), 0.024%, IS NOW APPROVED IN BRAZIL
Published:
2021-04-16
(Crawled : 06:00)
- globenewswire.com
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-71.16%
|
O:
0.3%
H:
0.36%
C:
-1.18%
brazil
approval
health
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.